Explore the full record of transactions filed by 강희철, Chairman & CEO. Insider active across 2 companies, notably 지에프씨생명과학. Aggregated, 24 filings have been published. Activity tracked since 9 March 2026. The latest transaction was filed on 9 April 2026 (Purchase). Regulator: DART (FSS). All data is openly available.
Kang Hee-cheol is the Chairman & CEO of GFC Life Science. He is responsible for the strategic direction of the company and the management of daily operations. With his experience, Kang Hee-cheol plays a key role in strategic decision-making and defining the company's long-term vision.